SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Apricus Biosciences
An SI Board Since September 2014
Posts SubjectMarks Bans Symbol
2026 18 0 APRI
Emcee:  mokelumne river Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
401Welcome Oldcoach! I agree with you that by second quarter 2015 we should have amokelumne river-11/28/2014
400I agree on Q2 15 results, Also I'm hoping Flibaserin gets approved by theeico20-11/28/2014
399Thanks Eman, glad to be here. I hope the launch in France gives us a little nudgoldcoach19-11/28/2014
398nice to hear from you oldcoach, I'm hoping to see a launch of Vitaros in Fraeico20-11/28/2014
397Hi everybody. I'm new to this board and wanted to take this opportunity to joldcoach19-11/28/2014
396Hey everybody, have a good Thanksgiving for those of us in the US, and for thosemokelumne river-11/26/2014
395Shazam, the Aspire purchases from the company are private purchases that do not mokelumne river-11/26/2014
394I'm not talking about the ATM. I'm just saying that those transactions mShazam619-11/26/2014
393true, partners want USA as well, we'll have to see how the FSIAD regulatory eico20-11/25/2014
392Agreed Eman...but there is still that thing about a European partner wanting a pmokelumne river-11/25/2014
391I agree, Fis. is a potential testosterone blockbuster in the USA and it has addeeico20-11/25/2014
390the near term benefit of Femprox would be some cash from an EU deal, if Flib. geeico20-11/25/2014
389Ah, good point Eman, I forgot that Flib is still in play. I think approval of Amokelumne river-11/25/2014
388What makes Fispemifene a BIG deal? Current sales of TRT drugs are over $2.5B peStarbuck2-11/25/2014
387good points James, makes sense, France reimbursement on Vitaros will be the nexteico20-11/25/2014
386Eman, you ask what will trigger a rise from the bargain basement to a much highemokelumne river-11/25/2014
385Shazam, I am not tracking. Apricus does not have an ATM anymore for direct markmokelumne river-11/25/2014
384thanks for the very good feedback from you guys, good points all around that maeico20-11/25/2014
383I think they diluted to pay for the RayVa phase 2a trial. That would explain theShazam619-11/25/2014
382Eman, I was curious to hear what David Collins would say to that question. I askStrong Long111/25/2014
381Well Eico. As a long term shareholder - obviously - I do not even like the thougMirror Image-11/25/2014
380I didn't notice earlier but it looks like the entire study is going to be comokelumne river-11/24/2014
379MI, what is your opinion of the current level of dilution, how is it contributineico20-11/24/2014
378Looks like the Phase 2a for RayVa is underway ( well at least they started recruMirror Image111/24/2014
377great info and perspective MI, hoping to see a Vitaros launch and reimbursementeico20-11/23/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News